Clinical Trial Update: ED50 and ED95 of Intranasal Dexmedetomidine in Pediatric Patients Undergoing Transthoracic Echocardiography Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating ED50 and ED95 of intranasal dexmedetomidine in pediatric patients undergoing transthoracic echocardiography.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthoracic Echocardiography Indications

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Guangzhou Women and Children's Medical Center | Conditions: Patients for Transthoracic Echocardiography, Unknown Diagnosis | Phase 4 | Status: COMPLETED